cancer treatment - newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra

ONGC’s CSR Initiative Powers Advanced Cancer Treatment at AIIMS Deoghar

Newsmantra — Mon, 27 Oct 2025 08:15:00 +0000

ONGC supported the procurement & installation of High Energy Linear Accelerators (HELA), a state-of-the-art radiotherapy equipment for Cancer treatment, in various Government Hospitals across India. One such critical equipment was inaugurated on 23 October 2025 at All India Institute of Medical Science (AIIMS) Deoghar (Jharkhand). This advanced facility will enable precise and effective Cancer Care, benefiting patients across Jharkhand and neighbouring regions.

The post ONGC’s CSR Initiative Powers Advanced Cancer Treatment at AIIMS Deoghar appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

CORE Diagnostics and CanCertain Healthcare Join Forces to Revolutionize Cancer Treatment

Newsmantra — Mon, 16 Oct 2023 05:16:29 +0000

New Delhi, India – CORE Diagnostics, a leading provider of advanced diagnostics solutions, is excited to announce a strategic collaboration with CanCertain Healthcare, a pioneering healthcare company dedicated to enhancing cancer treatment outcomes. This partnership marks a significant milestone in the field of oncology, aimed at revolutionizing how cancer patients receive personalized treatment.

Cancer is a daunting diagnosis that raises numerous questions and concerns for patients and their families. Questions about treatment options, cost, success rates, and potential side effects can create immense emotional distress. Oncologists are tasked with the challenging responsibility of swiftly determining the most effective treatment plans for each patient.

CanCertain Healthcare has set out to address this challenge with its groundbreaking CanCertain® test. By providing valuable insights into the sensitivity or resistance of a patient’s tumor to specific cancer drugs, this innovative diagnostic tool empowers oncologists to make more informed treatment decisions. This not only saves precious time but also reduces the financial burden of ineffective treatments.

“The CanCertain® test is a game-changer in the field of oncology,” states Dr. Shivani Sharma, Vice President of Pathology Services & Lab Director, CORE Diagnostics. “It allows us to identify the most effective drugs for a patient’s unique tumor and consider their individual immunity and drug resistance. By doing so, we minimize the need for multiple rounds of different drugs, safeguard the patient’s immune system, and significantly improve the chances of successful cancer treatment.”

This collaboration between CORE Diagnostics and CanCertain Healthcare is poised to reshape cancer care by bringing cutting-edge diagnostic capabilities to the forefront of oncology. The focus of this partnership is primarily on empowering healthcare providers and oncologists rather than direct patient interactions. Doctors will be equipped with the vital information needed to prescribe the most appropriate and effective treatments, optimizing the patient’s journey toward recovery.

Mr. Dinesh Chauhan, CEO, CORE Diagnostics, comments, “CORE Diagnostics is proud to partner with CanCertain Healthcare to enhance the precision and effectiveness of cancer treatment. Our combined expertise will not only benefit patients but also healthcare providers who strive to deliver the best possible care.”

CanCertain Healthcare’s mission aligns with CORE Diagnostics commitment to advancing healthcare through innovation. Together, they aim to improve patient outcomes, reduce the financial burden of cancer treatment, and provide hope to those affected by this devastating disease.

As we move forward, CORE Diagnostics and CanCertain Healthcare are excited about the transformative impact this collaboration will have on the field of oncology. By harnessing the power of advanced diagnostics, they aim to give cancer patients a fighting chance and make personalized cancer treatment a reality.

About CORE Diagnostics

CORE Diagnostics established its first lab in 2012 at Gurugram, which is NABL & CAP accredited. NABL is a constituent of the Quality Council of India, and CAP is the largest association in the world, certified by the American Board of Pathology. They have a team of 600 personnel committed to providing high-quality reports to patients. They currently have over 8500 prescribers and over 1000 clients, which include Hospitals, Clinics, Diagnostic Laboratories, NGOs, Pharmaceutical Companies, State Governments, and many more. They offer testing in many disease segments, some of which are – Oncology (onCŌRE), Gynecology (reproCŌRE), Gastroenterology (gastriCŌRE), Transplantation (xenoCŌRE), Nephrology (nephroCŌRE), Genetics (geneCŌRE) and Routine / Preventive Healthcare (vitaCŌRE), etc. They also have a team of MD/DM/Ph.D. doctors, including Onco-Pathologists, Hemato-Pathologists, Medical Geneticists, Cytogeneticists, Molecular Scientists, Pathologists, Histopathologists, and Biochemists.

The post CORE Diagnostics and CanCertain Healthcare Join Forces to Revolutionize Cancer Treatment appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

HCG Cancer Centre Jaipur unveils North India’s first-of-its-kind advanced Cutting-Edge Elekta Harmony Pro Radiotherapy Platform for Cancer treatment

Newsmantra — Thu, 28 Sep 2023 11:53:47 +0000

Jaipur, 28th September 2023: HCG Cancer Centre, Jaipur, one of the leading cancer hospitals, today unveiled the Elekta Harmony Pro Radiotherapy Platform, the most advanced linear accelerator system first of its kind in North India for cancer treatment. The state-of-the-art technology was inaugurated by Mr. Raj Gore, CEO, Healthcare Global Enterprises Limited and Shipra Vikram, project director, RGHS, in the presence Dr. Bharat Gadhavi, Regional Director, HCG, Mr. Bharat Rajpurohit, COO, HCG Cancer Centre Jaipur, doctors and HCG Staff.

HCG Cancer Centre Jaipur has been at the forefront of the battle against cancer, harnessing the expertise of highly skilled specialists and leveraging advanced technology to lead the combat. The introduction of Elekta Harmony Pro is a remarkable milestone in the center’s mission to provide world-class oncology care. It enables personalized and high-quality care for a broader spectrum of patients across North India.

The Elekta Harmony Pro Radiotherapy Platform is designed to deliver precise and efficient radiation therapy tailored to each patient’s unique needs. This advanced technology integrates precision, speed, and comfort to deliver highly targeted radiation therapy for cancer patients, also by reducing side effects and delivering treatment accuracy, thereby improving the overall quality of life for cancer patients. HCG is committed to delivering personalized care, and this technology will further elevate its ability to offer patient-centric treatment plans.

Speaking at the occasion, Mr. Raj Gore, CEO, Healthcare Global Enterprises Limited, said “HCG has been a pioneer in making comprehensive quality care accessible, affordable, and equitable to cancer patients across metro and non-metro cities. We have a consistent track record of being the first to introduce many advanced technologies in India to provide precise and personalized treatment tailored for each cancer patient. The introduction of the Elekta Harmony Pro Radiotherapy Platform marks another significant stride in this direction. We are honoured to have earned the trust of our patients in this great state of Rajasthan and we are committed to upholding that trust every day by extending and improving their lives.”

Dr. Bharat Gadhavi, Regional Director, Gujarat & Rajasthan, Healthcare Global Enterprises said, “We are honored to introduce Elekta Harmony Pro, a new standard in cancer care at HCG Cancer Centre Jaipur. Technology embodies the intersection of medical excellence and technological innovation, providing clinicians with a powerful tool to deliver personalized, targeted therapies that maximize the chances of recovery for patients. This milestone underscores our unwavering commitment to providing the best possible treatments and personalized care for those in need. We remain steadfast in our commitment to making a meaningful impact on the lives of cancer patients and their families.”

Speaking at the launch Mr. Bharat Rajpurohit, COO, HCG Cancer Centre Jaipur, said “Today, we mark a significant milestone in the advancement of cancer care in North India. The introduction of Elekta Harmony Pro at HCG Cancer Centre Jaipur exemplifies our commitment to providing cutting-edge treatments and elevating the standard of care for cancer patients. With the state-of-the-art system and cutting-edge technology, we are poised to revolutionize cancer treatment, offering precision, efficacy, and hope to enhance the lives of cancer patients”.

The launch of the Elekta Harmony Pro Radiotherapy Platform will mark a new chapter in the fight against cancer and serve as a testament to HCG Cancer Centre’s unwavering commitment to its mission. HCG Hospital Jaipur is the only comprehensive cancer care center in Rajasthan with all the facilities under one roof. The hospital provides ultra-modern cancer therapy to all patients with state-of-the-art technology backed by research and has consulted 1 lakh plus patients in the span of 5 years. The diagnostic facility contains cutting-edge nuclear imaging procedures – PET-CT (Positron Emission Tomography-Computed Tomography), which is a unique combination of metabolic and functional imaging (PET part) along with structural information (CT part).

The post HCG Cancer Centre Jaipur unveils North India’s first-of-its-kind advanced Cutting-Edge Elekta Harmony Pro Radiotherapy Platform for Cancer treatment appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.